The Benefits of Self-Insurance and ERISA’s Role in Employer Health Plans
Paul Fronstin, director of Health Benefits Research at EBRI, discussed ERISA and trends in employer self-insurance during a conversation with Managed Healthcare Executive recently.
In its 50th anniversary this year, the Employee Retirement Income Security Act (ERISA), continues to allow employers to self-insure their health plans, highlights Paul Fronstin, director of Health Benefits Research at EBRI.
Fronstin discussed ERISA and trends in employer self-insurance during a conversation with Managed Healthcare Executive recently.
While large employers tend to choose self-insurance for consistency across states, smaller and mid-sized employers are now adopting it since the Affordable Care Act.
However, some revert to fully insured models after poor experiences.
Employees benefit from self-insurance through consistent benefits nationwide, Fronstin said.
“(Employees) don’t have to think about a new plan, a different network, or changing prescription drugs,” he said.
While most large employers include state-mandated benefits such as IVF, exceptions exist, he said.
Overall, large employers tend to offer generous health plans. Fronstin concluded that understanding these dynamics remains key to evaluating the self-insurance model’s effectiveness.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
July 25th 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
July 24th 2025The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
Read More
